Cotinga Pharmaceuticals Announces Publication of Positive Data from Preclinical Study of COTI-2 in PLOS ONE
LONDON, ONTARIO and BOSTON, MASSACHUSETTS--(Marketwired - Jan 25, 2018) - Cotinga Pharmaceuticals Inc. (formerly Critical Outcome Technologies Inc.) (TSX VENTURE:COT)(OTCQB:COTQF) ("Cotinga" or the "Company"), a clinical-stage …